आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fentanylum inn - forðaplástur - 100 míkróg/klst.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fentanylum inn - forðaplástur - 25 míkróg/klst.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - fentanylum inn - forðaplástur - 75 míkróg/klst.

यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

actavis group ptc ehf - tópótecan - uterine cervical neoplasms; small cell lung carcinoma - Æxlishemjandi lyf - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. tópótecan ásamt cisplatíni er ætlað fyrir sjúklinga með krabbamein í legháls endurtekin eftir geislameðferð og fyrir sjúklinga með stigi ivb sjúkdómur. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 40 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 10 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 5 mg

आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml